- ¥572bn
- ¥542bn
- ¥404bn
- 98
- 45
- 99
- 96
Annual balance sheet for Biprogy, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
C2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 46,881 | 49,369 | 44,232 | 60,477 | 67,465 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 77,555 | 86,716 | 96,437 | 98,248 | 95,336 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 143,273 | 158,056 | 164,650 | 187,914 | 196,809 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 37,903 | 31,367 | 28,773 | 26,929 | 33,708 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 254,035 | 268,647 | 280,396 | 314,219 | 330,876 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 91,086 | 98,148 | 98,940 | 112,464 | 122,649 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 141,764 | 139,730 | 140,509 | 147,795 | 161,826 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 112,271 | 128,917 | 139,887 | 166,424 | 169,050 |
| Total Liabilities & Shareholders' Equity | 254,035 | 268,647 | 280,396 | 314,219 | 330,876 |
| Total Common Shares Outstanding |